SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001599298-21-000011
Filing Date
2021-03-31
Accepted
2021-03-31 16:50:32
Documents
116
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K smmt-20201231.htm   iXBRL 10-K 2314997
2 EX-10.35 sum-ex1035_20201231x10k.htm EX-10.35 88247
3 EX-10.36 sum-ex1036_20201231x10k.htm EX-10.36 54605
4 EX-21.1 sum-ex211_20201231x10k.htm EX-21.1 7962
5 EX-23.1 sum-ex231_20201231x10k.htm EX-23.1 2234
6 EX-31.1 sum-ex311_20201231x10k.htm EX-31.1 11754
7 EX-31.2 sum-ex312_20201231x10k.htm EX-31.2 11449
8 EX-32.1 sum-ex321_20201231x10k.htm EX-32.1 7866
14 image_01.jpg GRAPHIC 353706
15 smmt-20201231_g1.jpg GRAPHIC 56373
16 smmt-20201231_g2.jpg GRAPHIC 67638
17 smmt-20201231_g3.jpg GRAPHIC 31501
18 smmt-20201231_g4.jpg GRAPHIC 38237
19 smmt-20201231_g5.jpg GRAPHIC 69188
20 smmt-20201231_g6.jpg GRAPHIC 67057
  Complete submission text file 0001599298-21-000011.txt   10968231

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT smmt-20201231.xsd EX-101.SCH 71119
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT smmt-20201231_cal.xml EX-101.CAL 104087
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT smmt-20201231_def.xml EX-101.DEF 336443
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT smmt-20201231_lab.xml EX-101.LAB 778464
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT smmt-20201231_pre.xml EX-101.PRE 551262
21 EXTRACTED XBRL INSTANCE DOCUMENT smmt-20201231_htm.xml XML 1374167
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Filer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36866 | Film No.: 21794149
SIC: 2834 Pharmaceutical Preparations